Order Article Reprints

García-Betancur JC, De La Cadena E, Mojica MF, Hernández-Gómez C, Correa A, Radice MA, Castañeda-Méndez P, Jaime-Villalon DA, Gales AC, Munita JM, et al. Comparative In Vitro Activity of Ceftolozane/Tazobactam against Clinical Isolates of Pseudomonas aeruginosa and Enterobacterales from Five Latin American Countries. Antibiotics. 2022; 11(8):1101. https://doi.org/10.3390/antibiotics11081101

García-Betancur, Juan Carlos, Elsa De La Cadena, María F. Mojica, Cristhian Hernández-Gómez, Adriana Correa, Marcela A. Radice, Paulo Castañeda-Méndez, Diego A. Jaime-Villalon, Ana C. Gales, José M. Munita, and et al. 2022. "Comparative In Vitro Activity of Ceftolozane/Tazobactam against Clinical Isolates of Pseudomonas aeruginosa and Enterobacterales from Five Latin American Countries" Antibiotics 11, no. 8: 1101. https://doi.org/10.3390/antibiotics11081101

García-Betancur, J. C., De La Cadena, E., Mojica, M. F., Hernández-Gómez, C., Correa, A., Radice, M. A., Castañeda-Méndez, P., Jaime-Villalon, D. A., Gales, A. C., Munita, J. M., & Villegas, M. V. (2022). Comparative In Vitro Activity of Ceftolozane/Tazobactam against Clinical Isolates of Pseudomonas aeruginosa and Enterobacterales from Five Latin American Countries. Antibiotics, 11(8), 1101. https://doi.org/10.3390/antibiotics11081101